| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,928 |
29,149 |
$6.82M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,595 |
16,816 |
$5.18M |
| 80053 |
Comprehensive metabolic panel |
19,866 |
18,190 |
$748K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,415 |
1,082 |
$501K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,815 |
5,300 |
$305K |
| 87631 |
|
2,265 |
2,102 |
$296K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,071 |
1,799 |
$220K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
522 |
489 |
$208K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,407 |
17,612 |
$187K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,075 |
2,737 |
$176K |
| 36415 |
Collection of venous blood by venipuncture |
22,961 |
20,559 |
$158K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
642 |
607 |
$122K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,489 |
2,386 |
$117K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,446 |
2,903 |
$115K |
| 81001 |
|
10,572 |
9,733 |
$115K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,379 |
4,613 |
$84K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,733 |
4,214 |
$84K |
| 71046 |
Radiologic examination, chest; 2 views |
1,241 |
1,015 |
$62K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
206 |
184 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,830 |
1,719 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,027 |
471 |
$47K |
| 80061 |
Lipid panel |
1,894 |
1,779 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
515 |
463 |
$40K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,116 |
1,996 |
$38K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,583 |
1,450 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
957 |
865 |
$34K |
| 0012A |
|
1,529 |
1,329 |
$31K |
| 84484 |
|
1,351 |
1,017 |
$27K |
| 0011A |
|
1,640 |
1,387 |
$25K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
286 |
278 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
617 |
557 |
$24K |
| 70450 |
Computed tomography, head or brain; without contrast material |
145 |
124 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
483 |
419 |
$22K |
| 0001A |
|
539 |
512 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
226 |
213 |
$16K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,945 |
5,322 |
$15K |
| 0002A |
|
461 |
443 |
$15K |
| 83690 |
|
1,508 |
1,365 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,874 |
1,684 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
537 |
492 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
56 |
52 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,695 |
2,468 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,662 |
1,512 |
$7K |
| 90686 |
|
553 |
530 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
79 |
79 |
$7K |
| 81025 |
|
471 |
444 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
160 |
155 |
$5K |
| 83735 |
|
252 |
231 |
$5K |
| 86803 |
|
102 |
99 |
$4K |
| 80306 |
|
41 |
38 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
44 |
44 |
$3K |
| 85027 |
|
196 |
186 |
$3K |
| 0004A |
|
97 |
89 |
$3K |
| 0064A |
|
82 |
75 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
132 |
127 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
43 |
38 |
$2K |
| 85730 |
|
60 |
53 |
$2K |
| 84145 |
|
12 |
12 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
124 |
112 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14 |
12 |
$1K |
| 87077 |
|
33 |
25 |
$689.65 |
| 96160 |
|
166 |
164 |
$491.18 |
| 0071A |
|
12 |
12 |
$444.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
12 |
$405.93 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
15 |
$388.92 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
167 |
147 |
$386.72 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
34 |
32 |
$385.80 |
| 83718 |
|
27 |
27 |
$351.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
88 |
82 |
$346.90 |
| 84478 |
|
27 |
27 |
$323.19 |
| 90715 |
|
15 |
15 |
$306.52 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
12 |
$304.73 |
| 87081 |
|
70 |
64 |
$284.96 |
| 83605 |
|
39 |
33 |
$193.35 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
141 |
120 |
$173.02 |
| 87070 |
|
13 |
13 |
$161.02 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
12 |
12 |
$157.68 |
| 82248 |
|
13 |
13 |
$138.36 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
27 |
$128.80 |
| 82553 |
|
43 |
37 |
$127.28 |
| J1790 |
Injection, droperidol, up to 5 mg |
29 |
26 |
$108.32 |
| J3490 |
Unclassified drugs |
18 |
13 |
$107.95 |
| 82550 |
|
43 |
37 |
$96.35 |
| 85379 |
|
15 |
13 |
$96.14 |
| 90651 |
|
17 |
17 |
$91.74 |
| 85610 |
|
93 |
81 |
$82.20 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
12 |
$79.80 |
| 82728 |
|
13 |
12 |
$71.06 |
| 96127 |
|
13 |
12 |
$69.60 |
| 99173 |
|
101 |
98 |
$68.38 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
85 |
50 |
$59.38 |
| 81003 |
|
13 |
13 |
$52.00 |
| 82607 |
|
13 |
12 |
$46.36 |
| 82746 |
|
13 |
12 |
$44.84 |
| 82150 |
|
16 |
14 |
$43.12 |
| 83540 |
|
13 |
12 |
$38.81 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$34.30 |
| 99442 |
|
50 |
41 |
$27.20 |
| 84703 |
|
28 |
25 |
$10.52 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$8.43 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$0.17 |
| 99406 |
|
16 |
13 |
$0.00 |